Refreshing results…
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
UploadIn vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Download from www.nature.comMissing publications? Search for publications with a matching author name.